INSPECS Group plc (AIM:SPEC)
London
· Delayed Price · Currency is GBP · Price in GBX 46.88
-0.12 (-0.26%)
Jun 17, 2025, 11:44 AM GMT+1
INSPECS Group Market Cap
INSPECS Group has a market cap or net worth of 47.79 million as of June 17, 2025. Its market cap has decreased by -38.16% in one year.
Market Cap
47.79M
Enterprise Value
86.29M
Revenue
198.26M
Ranking
n/a
PE Ratio
n/a
Stock Price
46.88
Market Cap Chart
Since February 27, 2020, INSPECS Group's market cap has decreased from 137.95M to 47.79M, a decrease of -65.36%. That is a compound annual growth rate of -18.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2025 | 47.79M | 3.30% |
| Dec 31, 2024 | 46.26M | -45.83% |
| Dec 29, 2023 | 85.40M | 95.35% |
| Dec 30, 2022 | 43.72M | -88.33% |
| Dec 31, 2021 | 374.78M | 12.12% |
| Dec 31, 2020 | 334.26M | 142.30% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 170.36B |
| GSK plc | 61.23B |
| Haleon | 35.62B |
| Smith & Nephew | 9.57B |
| ConvaTec Group | 5.88B |
| Hikma Pharmaceuticals | 4.69B |
| HUTCHMED (China) | 2.15B |
| Genus | 1.30B |